Financials
- Market Capitalization 1.83 B
- Employee 47
- Founded 1998
- CEO Helen Sabzevari
- Website www.precigen.com
- Headquarter Virginia, United States
- FIGI BBG000QL8VH9
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 2040 | NTLA Intellia Therapeutics, Inc. - Common Stock | 13.30 USD | +2.15% | -20.88% | -9.95% | -3.06% | 1.86 B USD | ||
| 2046 | BCAX Bicara Therapeutics Inc. - Common Stock | 28.10 USD | -0.18% | -6.05% | +30.58% | +94.60% | 1.85 B USD | ||
| 2058 | ANAB AnaptysBio, Inc. - Common Stock | 62.51 USD | -10.46% | -6.55% | +4.18% | +77.59% | 1.82 B USD | ||
| 2059 | ZBIO Zenas BioPharma, Inc. - Common Stock | 28.78 USD | +3.23% | +5.19% | +53.41% | +8.77% | 1.82 B USD |